Description
An antispasmodic agent; inhibits electrically induced urinary bladder contractions in dogs (ED50s = 0.07-4.7 mg/kg); decreases the ileal PMI as well as colonic motility in canine models of ileal and colonic fistulas, respectively
Formal name: (1α,2β,4β,5α,7β)-9-butyl-7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane, monobromide
Synonyms: Hyoscine butobromide|N-butyl Hyoscine
Molecular weight: 440.4
CAS: 149-64-4
Purity: ≥95%
Formulation: A solid
Product Type|Biochemicals||Research Area|Neuroscience|Pain Research